CD24 and ovarian cancer: Administration with CD24-shRNA in vivo suppressed tumor volume increase by microvessel density (MVD) decrease, cell proliferation inhibition, and apoptosis induction, suggesting that knockdown of CD24 may be a potential method for the treatment of human ovarian cancer (104).